Skip to content
Healthcare, Pharmaceuticals & Life Sciences →

Pharmaceuticals & Bulk Drugs Regulations, DPCO & API Policy Updates

Daily notifications on Drugs & Cosmetics Act amendments, NPPA drug price control orders (DPCO), Bulk Drug Parks, and API PLI schemes.

Coverage: Central & State Gazette Notifications
Cadence: Daily Real-Time Updates

Pharmaceuticals & Bulk Drugs Regulatory Landscape & Compliance Overview

Official Intelligence

PolicyIndex indexes real-time gazette notifications, policy orders, tariff determinations, and compliance circulars issued across the Pharmaceuticals & Bulk Drugs sector. Regulatory intelligence is aggregated across central ministries, state regulatory commissions, and statutory authorities.

Statutory Directives

Official Extraordinary Gazettes, S.O. & G.S.R. orders, and executive notifications.

Compliance Mandates

Sector-specific regulatory obligations, licensing norms, and statutory filing guidelines.

Key Focus Areas: drugs cosmetics act dpco price ceiling nppa bulk drug park scheme api pli scheme clinical trial rules india

Other Verticals in Healthcare, Pharmaceuticals & Life Sciences

Medical Devices & Diagnostics AYUSH & Nutraceuticals Hospitals & Digital Health
Strategic Intelligence

Looking for Weekly Policy & Regulatory Briefings?

Access curated sector roundups, executive summaries, and downloadable PDF intelligence reports.

Browse Weekly Roundups →

Latest Pharmaceuticals & Bulk Drugs News & Analysis

Pharmaceuticals & Bulk Drugs

Odisha Semiconductor Push: Two Plants to Create 1,280 Jobs

Odisha is set to anchor two major semiconductor manufacturing facilities under the Semicon India Programme, generating over 1,280 direct hig...

By Policy & Regulatory Editorial Desk 2026-08-24
Pharmaceuticals & Bulk Drugs

89% Reserved Train Tickets Booked Online, Says Railway Ministry

Indian Railways has reported that nearly 89 percent of reserved train tickets are now booked online, compared to 49 percent a decade ago. Th...

By Policy & Regulatory Editorial Desk 2026-08-24
Pharmaceuticals & Bulk Drugs

SEBI Chief Urges Shift From Compliance to Stewardship for Corporate Boards

Speaking at the Institute of Directors Annual Conclave, SEBI Chairman Tuhin Kanta Pandey urged corporate boards and independent directors to...

By Policy & Regulatory Editorial Desk 2026-08-24
Pharmaceuticals & Bulk Drugs

Centre Enforces MMDR Amendment Act 2026 on Mining Taxes

The Ministry of Mines has notified the immediate commencement of the MMDR Amendment Act, 2026. The law restricts state governments from levy...

By Policy & Regulatory Editorial Desk 2026-08-24
Pharmaceuticals & Bulk Drugs

Centre Limits State Taxes on Mineral Rights in MMDR Amendment

Parliament has enacted the Mines and Minerals (Development and Regulation) Amendment Act, 2026, prohibiting state governments from imposing ...

By Policy & Regulatory Editorial Desk 2026-08-24
Pharmaceuticals & Bulk Drugs

India Enforces MMDR Amendment Act 2026 to Overhaul Mining Fiscal Rules and Captive Sales

The Ministry of Mines has notified August 22, 2026, as the official commencement date for the Mines and Minerals (Development and Regulation...

By Policy & Regulatory Editorial Desk 2026-08-24

Official Pharmaceuticals & Bulk Drugs Gazettes & Notifications

Frequently Asked Questions on Pharmaceuticals & Bulk Drugs Regulations

What is the function of NPPA in drug pricing?

The National Pharmaceutical Pricing Authority (NPPA) fixes and revises prices of controlled bulk drugs and formulations under the DPCO to ensure drug affordability.

Get daily policy updates in your inbox

Choose the sectors and regulators you care about. We'll send only what matters to you.

No spam. Unsubscribe anytime.